Literature DB >> 23243110

Knowledge, attitudes, and practices regarding Rocky Mountain spotted fever among healthcare providers, Tennessee, 2009.

Emily Mosites1, L Rand Carpenter, Kristina McElroy, Mary J Lancaster, Tue H Ngo, Jennifer McQuiston, Caleb Wiedeman, John R Dunn.   

Abstract

Tennessee has a high incidence of Rocky Mountain spotted fever (RMSF), the most severe tick-borne rickettsial illness in the United States. Some regions in Tennessee have reported increased illness severity and death. Healthcare providers in all regions of Tennessee were surveyed to assess knowledge, attitudes, and perceptions regarding RMSF. Providers were sent a questionnaire regarding knowledge of treatment, diagnosis, and public health reporting awareness. Responses were compared by region of practice within the state, specialty, and degree. A high proportion of respondents were unaware that doxycycline is the treatment of choice in children ≤ 8 years of age. Physicians practicing in emergency medicine, internal medicine, and family medicine; and nurse practitioners, physician assistants, and providers practicing for < 20 years demonstrated less knowledge regarding RMSF. The gaps in knowledge identified between specialties, designations, and years of experience can help target education regarding RMSF.

Entities:  

Mesh：

Year:  2012        PMID： 23243110      PMCID： PMC3541729          DOI： 10.4269/ajtmh.2012.12-0126

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  11 in total

1.  Analysis of risk factors for fatal Rocky Mountain Spotted Fever: evidence for superiority of tetracyclines for therapy.

Authors:  R C Holman; C D Paddock; A T Curns; J W Krebs; J H McQuiston; J E Childs
Journal:  J Infect Dis       Date:  2001-11-13       Impact factor: 5.226

2.  Spatial clustering by disease severity among reported Rocky Mountain spotted fever cases in the United States, 2001-2005.

Authors:  Jennifer Zipser Adjemian; John Krebs; Eric Mandel; Jennifer McQuiston
Journal:  Am J Trop Med Hyg       Date:  2009-01       Impact factor: 2.345

3.  Doxycycline and staining of permanent teeth.

Authors:  M E Lochary; P B Lockhart; W T Williams
Journal:  Pediatr Infect Dis J       Date:  1998-05       Impact factor: 2.129

4.  Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence.

Authors:  John J Openshaw; David L Swerdlow; John W Krebs; Robert C Holman; Eric Mandel; Alexis Harvey; Dana Haberling; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2010-07       Impact factor: 2.345

5.  Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases.

Authors:  C G Helmick; K W Bernard; L J D'Angelo
Journal:  J Infect Dis       Date:  1984-10       Impact factor: 5.226

6.  Consequences of delayed diagnosis of Rocky Mountain spotted fever in children--West Virginia, Michigan, Tennessee, and Oklahoma, May-July 2000.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-10-06       Impact factor: 17.586

7.  Doxycycline use for rickettsial disease in pediatric patients.

Authors:  J J Purvis; M S Edwards
Journal:  Pediatr Infect Dis J       Date:  2000-09       Impact factor: 2.129

8.  Clinical and laboratory features, hospital course, and outcome of Rocky Mountain spotted fever in children.

Authors:  Steven C Buckingham; Gary S Marshall; Gordon E Schutze; Charles R Woods; Mary Anne Jackson; Lori E R Patterson; Richard F Jacobs
Journal:  J Pediatr       Date:  2007-02       Impact factor: 4.406

9.  Therapeutic delay and mortality in cases of Rocky Mountain spotted fever.

Authors:  K B Kirkland; W E Wilkinson; D J Sexton
Journal:  Clin Infect Dis       Date:  1995-05       Impact factor: 9.079

10.  Physician knowledge of the diagnosis and management of Rocky Mountain spotted fever: Mississippi, 2002.

Authors:  M O'Reilly; C Paddock; B Elchos; J Goddard; J Childs; M Currie
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691
View more
  8 in total

1.  Increasing Incidence of Ehrlichiosis in the United States: A Summary of National Surveillance of Ehrlichia chaffeensis and Ehrlichia ewingii Infections in the United States, 2008-2012.

Authors:  Kristen Nichols Heitman; F Scott Dahlgren; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-11-30       Impact factor: 2.345

2.  Self-reported treatment practices by healthcare providers could lead to death from Rocky Mountain spotted fever.

Authors:  Jillian Zientek; F Scott Dahlgren; Jennifer H McQuiston; Joanna Regan
Journal:  J Pediatr       Date:  2013-11-16       Impact factor: 4.406

3.  Impact of a Severe Rocky Mountain Spotted Fever Case on Treatment Practices at an Academic Institution Within a Nonendemic Area.

Authors:  Conrad Krawiec; Gary D Ceneviva; Shouhao Zhou; Neal J Thomas
Journal:  Wilderness Environ Med       Date:  2021-08-12       Impact factor: 1.518

4.  Challenges to Arboviral Surveillance in Tennessee: Health-Care Providers' Attitudes and Behaviors.

Authors:  Julie Shaffner; Timothy F Jones; Abelardo C Moncayo
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

5.  Targeted knockout of the Rickettsia rickettsii OmpA surface antigen does not diminish virulence in a mammalian model system.

Authors:  Nicholas F Noriea; Tina R Clark; Ted Hackstadt
Journal:  MBio       Date:  2015-03-31       Impact factor: 7.867

6.  The Rickettsial Ankyrin Repeat Protein 2 Is a Type IV Secreted Effector That Associates with the Endoplasmic Reticulum.

Authors:  Stephanie S Lehman; Nicholas F Noriea; Karin Aistleitner; Tina R Clark; Cheryl A Dooley; Vinod Nair; Simran Jeet Kaur; M Sayeedur Rahman; Joseph J Gillespie; Abdu F Azad; Ted Hackstadt
Journal:  mBio       Date:  2018-06-26       Impact factor: 7.867

7.  Patient characteristics, treatment patterns, and outcomes of Rickettsial diseases among a commercially insured population in the United States, 2005-2017.

Authors:  Alison M Binder; Paige A Armstrong
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.996

8.  Assessment of Risk Factors and Outcomes of Severe Ehrlichiosis Infection.

Authors:  Kevin Kuriakose; April C Pettit; Jonathan Schmitz; Abelardo Moncayo; Karen C Bloch
Journal:  JAMA Netw Open       Date:  2020-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.